IP Verse

Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab

Patent No. EP4403228 (titled "Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab") was filed by F Hoffmann LA Roche on Oct 11, 2012. The application was issued on Jul 16, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STORZApr 16, 2026-
BRAND MURRAY FULLERApr 8, 2026BRAND MURRAY FULLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4403228

F HOFFMANN LA ROCHE
Application Number
EP24174637A
Filing Date
Oct 11, 2012
Status
Granted And Under Opposition
Jun 13, 2025
Publication Date
Jul 16, 2025
External Links
Slate, Register , Google Patents